Fig. 1From: Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphomaChanges in relative survivin mRNA expression in tumor tissue and peripheral blood mononuclear cells following EZN-3042 treatment in dogs with spontaneous lymphoma.a. Changes in tumor tissue. b. Changes in peripheral blood mononuclear cells in dogs treated at the highest 2 dose levelsBack to article page